cardiovascular disease

Exscientia lands multi-million euro deal with Bayer
By Leontina Postelnicu | 08:56 am | January 10, 2020
Bayer and Exscientia will initially work on three early-stage projects using AI to speed up drug discovery.
Roundup: 16 digital health studies, pilots and reviews from AHA 2019
By Dave Muoio | 05:18 pm | November 22, 2019
From mobile ECGs to tele-rehabilitation to defibrillator delivery drones, a range of new data was on display at the American Heart Association Scientific Sessions 2019.
Ultromics receives FDA clearance for its AI-powered decision support system
By Tammy Lovell | 03:08 am | November 18, 2019
EchoGo helps earlier detection of cardiovascular disease, enabling clinicians to improve patient care and outcomes.
Eleven startups join Bayer’s G4A Digital Health Partnerships programme
By Leontina Postelnicu | 09:14 am | October 14, 2019
These include Wellthy Therapeutics, from India; OKKO Health, from the UK; and Carepay, from Kenya. 
Blending high touch with high tech, Healthy Interactions adds depression, CVD modules
By Jonah Comstock | 05:13 pm | July 02, 2018
Algorithm highlights cardiovascular disease using smartphone's camera
By Dave Muoio | 04:45 pm | April 20, 2018
Google AI now can predict cardiovascular problems from retinal scans
By Bill Siwicki | 11:40 am | February 20, 2018
Four ways the AHA thinks mobile health research needs to improve
By Jonah Comstock | 07:12 am | August 17, 2015
Mayo Clinic analysis finds digital health interventions reduce cardiovascular disease risk
By Jonah Comstock | 11:47 am | May 07, 2015
Mayo Clinic study finds app reduces cardiac readmissions by 40 percent
By Jonah Comstock | 01:02 pm | April 01, 2014